What I do:
I am now developing a new therapeutic approach and reagents that will enhance complement-mediated microbial killing. These reagents are highly potent recombinant bi-specific antibodies that eradicate bacteria via complement-mediated lysis and phagocytosis. This finding has been filed as a patent entitled “Targeted catalytic complement-activating molecules and methods of use thereof”.
Research Interests:
Role of complement system in immune defense against microbial and viral infection
Key Projects, Countries, and Partners:
I have close contact with the microbiology group at Mansoura University, Egypt. This group is interested innisolation and Identification of Bacteriophage for the treatment of multidrug resistance bacteria.
